CIK: 0001582844 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $177,652 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RAYZEBIO INC | 378,069 | $23,505 | 13.2% | $25.74 | — | COM | 75525N107 |
| — | CYMABAY THERAPEUTICS INC | 492,155 | $11,625 | 6.5% | $8.88 | — | COM | 23257D103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 366,015 | $10,969 | 6.2% | $18.58 | +18.8% | COM | 77313F106 |
| KURA | KURA ONCOLOGY INC | 701,349 | $10,085 | 5.7% | $14.15 | -30.5% | COM | 50127T109 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 425,128 | $9,825 | 5.5% | $10.45 | +7.0% | COM NEW | 30233G209 |
| PCVX | VAXCYTE INC | 117,373 | $7,371 | 4.1% | $31.29 | +66.0% | COM | 92243G108 |
| SRPT | SAREPTA THERAPEUTICS INC | 70,600 | $6,808 | 3.8% | $99.68 | -3.8% | COM | 803607100 |
| PRAX | PRAXIS PRECISION MEDICINES I | 299,636 | $6,676 | 3.8% | $18.01 | 0.0% | COM | 74006W207 |
| IRON | DISC MEDICINE INC | 115,500 | $6,671 | 3.8% | $35.48 | +44.3% | COM | 254604101 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,589,333 | $6,353 | 3.6% | $1.87 | +6.7% | COM SHS | 877619106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 281,500 | $6,131 | 3.5% | $19.02 | -17.0% | COM | 92790C104 |
| — | TOURMALINE BIO INC. | 231,882 | $6,071 | 3.4% | $26.18 | — | COM | 89157D105 |
| OCUL | OCULAR THERAPEUTIX INC | 1,310,000 | $5,843 | 3.3% | $2.96 | 0.0% | COM | 67576A100 |
| — | MERSANA THERAPEUTICS INC | 2,368,000 | $5,494 | 3.1% | $2.28 | — | COM | 59045L106 |
| — | HILLEVAX INC | 324,600 | $5,210 | 2.9% | $14.60 | — | COM | 43157M102 |
| IMVT | IMMUNOVANT INC | 119,489 | $5,034 | 2.8% | $18.65 | +97.3% | COM | 45258J102 |
| RVMD | REVOLUTION MEDICINES INC | 160,000 | $4,589 | 2.6% | $24.03 | 0.0% | COM | 76155X100 |
| APLS | APELLIS PHARMACEUTICALS INC | 76,100 | $4,555 | 2.6% | $44.70 | +13.5% | COM | 03753U106 |
| ACLX | ARCELLX INC | 77,000 | $4,274 | 2.4% | $45.11 | 0.0% | COMMON STOCK | 03940C100 |
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $3,736 | 2.1% | $27.48 | -84.7% | COM | 00032Q104 |
| TERN | TERNS PHARMACEUTICALS INC | 555,260 | $3,604 | 2.0% | $5.72 | -7.6% | COM | 880881107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 87,500 | $3,113 | 1.8% | $20.61 | +48.8% | COM | 22663K107 |
| CLDX | CELLDEX THERAPEUTICS INC | 69,400 | $2,752 | 1.5% | $9.46 | +210.8% | COM NEW | 15117B202 |
| ANTX | AN2 THERAPEUTICS INC | 132,000 | $2,705 | 1.5% | $16.19 | +3.4% | COM | 037326105 |
| DYN | DYNE THERAPEUTICS INC | 147,836 | $1,966 | 1.1% | $11.28 | -13.4% | COM | 26818M108 |
| VSTM | VERASTEM INC | 232,249 | $1,891 | 1.1% | $6.94 | +3.5% | COM NEW | 92337C203 |
| — | APPLIED THERAPEUTICS INC | 525,100 | $1,759 | 1.0% | $3.35 | — | COM | 03828A101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 123,876 | $1,714 | 1.0% | $18.94 | -35.4% | COM | 29337E102 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 74,500 | $1,509 | 0.8% | $13.16 | 0.0% | COM | 35104E100 |
| CYPH | LEAP THERAPEUTICS INC | 354,166 | $1,468 | 0.8% | $2.32 | -6.9% | COM NEW | 52187K200 |
| — | CELLECTAR BIOSCIENCES INC | 477,500 | $1,323 | 0.7% | $2.74 | — | COM NEW | 15117F807 |
| INSM | INSMED INC | 29,500 | $914 | 0.5% | $25.93 | 0.0% | COM PAR $.01 | 457669307 |
| ARGX | ARGENX SE - ADR | 2,400 | $913 | 0.5% | $380.43 | — | SPONSORED ADR | 04016X101 |
| — | VERONA PHARMA PLC | 19,000 | $378 | 0.2% | $19.88 | — | SPONSORED ADS | 925050106 |
| — | SPRINGWORKS THERAPEUTICS INC | 10,000 | $365 | 0.2% | $36.50 | — | COM | 85205L107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 38,138 | $304 | 0.2% | $6.47 | — | SPONSORED ADS | 152309100 |
| TYRA | TYRA BIOSCIENCES INC | 8,867 | $123 | 0.1% | $12.95 | 0.0% | COM | 90240B106 |
| AVXL | ANAVEX LIFE SCIENCES CORP | 1,000 | $23 | 0.0% | — | — | Put | 032797300 |
| — | NUVATION BIO | 90,832 | $5 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |